Sarah Cannon Research Institute shared on LinkedIn:
“At the 2026 ESMO Annual Meeting in Madrid, Sarah Cannon Research Institute (SCRI) investigators contributed more than 85 abstracts and presentations across the network.
From antibody-drug conjugates to immunotherapies and bispecific antibodies, their work explored new treatment approaches with a shared goal: creating more possibilities for patients.”
You can also read: 25 Posts Not to Miss from ESMO Congress 2026: Day 5
